OncoSil Medical Ltd (AU:OSL) has released an update.
OncoSil Medical Ltd is set to raise $2.7 million through the issuance of 385.7 million new shares and options, targeting sophisticated investors with the sales being speculative and presenting a risk of variable returns. The funds are poised to bolster the company’s financial position, with shares priced attractively at $0.007 each, accompanied by an equal number of short-dated options. Investors are urged to consider these securities as high-risk, with no guarantees on capital return or dividends, and to seek professional advice before investing.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.